These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 8782208)
21. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis. A comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry, and p53. Oshiro Y; Fukuda T; Tsuneyoshi M Am J Surg Pathol; 1994 Jul; 18(7):712-9. PubMed ID: 7517104 [TBL] [Abstract][Full Text] [Related]
22. Image cytometric comparison of proliferating cell nuclear antigen and MIB-1 staining in hepatocellular carcinoma and adjacent liver tissue. Wells SJ; DeRose PB; Cohen C Cytometry; 1996 Sep; 26(3):198-203. PubMed ID: 8889391 [TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms. Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113 [TBL] [Abstract][Full Text] [Related]
25. Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. Fontanini G; Pingitore R; Bigini D; Vignati S; Pepe S; Ruggiero A; Macchiarini P Am J Pathol; 1992 Dec; 141(6):1285-90. PubMed ID: 1361306 [TBL] [Abstract][Full Text] [Related]
26. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast. Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265 [TBL] [Abstract][Full Text] [Related]
27. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms. Steck K; el-Naggar AK Cytometry; 1994 Nov; 17(3):258-65. PubMed ID: 7851161 [TBL] [Abstract][Full Text] [Related]
28. A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry. Parrado C; Falkmer UG; Höög A; Falkmer S; Ahrens O; Rius F; Grimelius L Gen Diagn Pathol; 1996 Mar; 141(3-4):215-27. PubMed ID: 8705786 [TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma. Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009 [TBL] [Abstract][Full Text] [Related]
30. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression. Martín R; Nieto S; Santamaría L Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical detection of cell-cycle associated markers on paraffin embedded and formalin fixed needle biopsies of prostate cancer: correlation of p120 protein expression with AgNOR, PCNA/cyclin, Ki-67/MIB1 proliferation-scores and Gleason gradings. Botticelli AR; Casali AM; Botticelli L; Zaffe D Eur J Histochem; 1998; 42(1):41-8. PubMed ID: 9615190 [TBL] [Abstract][Full Text] [Related]
32. Flow cytometric DNA analysis of ulcerative colitis using paraffin-embedded biopsy specimens: comparison with morphology and DNA analysis of fresh samples. Hartmann DP; Montgomery EA; Carr NJ; Gupta PK; Azumi N Am J Gastroenterol; 1995 Apr; 90(4):590-6. PubMed ID: 7717317 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical detection of proliferative cells. Mokrý J; Nĕmecek S Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626 [TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry. Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053 [TBL] [Abstract][Full Text] [Related]
35. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract. Lee CS Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306 [TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies. Markiewski M; Domagała W Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711 [TBL] [Abstract][Full Text] [Related]
37. Methodological aspects of using immunohistochemical cell proliferation biomarkers in colorectal carcinoma chemoprevention. Risio M J Cell Biochem Suppl; 1994; 19():61-7. PubMed ID: 7823607 [TBL] [Abstract][Full Text] [Related]
38. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value. Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111 [TBL] [Abstract][Full Text] [Related]
39. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer. Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314 [TBL] [Abstract][Full Text] [Related]
40. MIB-1 immunostaining and DNA flow cytometry in meningiomas. Yasue M; Akasaki Y; Numoto TR; Abe S; Abe T; Takeuchi Y; Tanaka J Noshuyo Byori; 1996 Apr; 13(1):17-20. PubMed ID: 8916122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]